Key result
Rutaecarpine inhibits pulmonary artery smooth muscle cell proliferation and promotes apoptosis in hypoxia via HIF-1α.
Why the study?
Does Rutaecarpine suppress proliferation and promote apoptosis in hypoxia-induced human pulmonary artery smooth muscle cells?
Does Rutaecarpine suppress proliferation and promote apoptosis in hypoxia-induced human pulmonary artery smooth muscle cells?
Rutaecarpine exerts protective effects against hypoxia in human pulmonary artery smooth muscle cells by suppressing proliferation and promoting apoptosis via HIF-1α-dependent pathways, suggesting potential therapeutic value for pulmonary hypertension.
May support preclinical testing in pulmonary hypertension models; leaves open clinical translation from in vitro data alone.
PURPOSE: The aim of this study is to investigate the potential roles of Rutaecarpine (Rut) in hypoxia-induced human pulmonary artery smooth muscle cells (HPASMCs) model. METHODS: HPASMCs were cultured with or without hypoxia followed by Rut administration. Cytotoxicity and cell proliferation were assessed by CCK-8 and Cell counting method. Flow cytometry was used for the measurement of cell apoptosis rates. The mRNA expression of hypoxia-induced factor (HIF)-1α and protein levels of HIF-1α, p53, p21, erythropoietin, and vascular endothelial growth factor were determined by quantitative real-time polymerase chain reaction and Western blot, respectively. RESULTS: Rut inhibited the proliferation of HPASMCs with IC50 value of 43.5 μmol·L. Hypoxia significantly increased proliferation and decreased apoptosis in HPASMCs, whereas Rut rescued this phenomenon at the appropriate concentration. Meanwhile, Rut effectively decreased the protein and mRNA expressions of HIF-1α. Knockdown of HIF-1α expression by small interfering RNA (siRNA) significantly enhanced the proapoptotic effect rather than antiproliferation effect of Rut in HPASMCs. Moreover, Rut simultaneously reduced proliferating cell nuclear antigen protein expression, whereas increased p53 and p21 protein levels. However, no significant difference was observed in the protein levels of vascular endothelial growth factor and erythropoietin. CONCLUSIONS: Our results demonstrated that Rut exerted protective effects on HPASMCs against hypoxia partly through the HIF-1α-dependent signaling pathway.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2018) studied Hypoxia-induced human pulmonary artery smooth muscle cells (HPASMCs) model. Rutaecarpine vs. No Rutaecarpine / No hypoxia was evaluated on Cell proliferation and apoptosis. Rutaecarpine inhibited the proliferation of human pulmonary artery smooth muscle cells with an IC50 of 43.5 μmol/L and promoted apoptosis in hypoxia via the HIF-1α-dependent signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: